Illinois launched a $3M X‑Labs Fast Fund to entice NSF quantum teams to build in Chicago, pairing state cash with partner lab access at the new IQMP campus.

A germline‑targeting HIV vaccine produced broadly neutralizing antibodies in about 44% of vaccinated primates, researchers report. The Nature study is a proof‑of‑principle but not proof of protection.

St. Jude is recruiting Memphis volunteers for a Phase 3 trial testing a once‑monthly HIV prevention pill; eligibility opens at age 16. The EXPrESSIVE‑11 study compares monthly MK‑8527 with daily PrEP.